Copyright
©The Author(s) 2017.
World J Hepatol. Apr 28, 2017; 9(12): 603-612
Published online Apr 28, 2017. doi: 10.4254/wjh.v9.i12.603
Published online Apr 28, 2017. doi: 10.4254/wjh.v9.i12.603
Table 1 Demographics and clinical characteristics
Sub-maximally dilated | Maximally dilated | P value | |
Total patients | 43 | 230 | NA |
Male | 23 | 150 | 0.17 |
Female | 20 | 80 | |
Mean age (yr) | 56.5 ± 2.3 (range 10-83) | 54.5 ± 0.7 (range 20-81) | 0.29 |
Mean MELD | 13.6 ± 0.6 (range 6-25) | 13.5 ± 0.3 (range 6-28) | 0.82 |
Mean pre-TIPS PSG (mmHg) | 19.4 ± 6.8 (range 8-45) | 22.4 ± 7.1 (range 9-73) | 0.01 |
Median post-TIPS PSG (mmHg) | 8 (range 1-13) | 8 (range 2-20) | 0.13 |
Mean percent change in PSG (%) | 59.1 ± 15.9 (range 0-95) | 61.0 ± 12.4 (range 0-89) | 0.53 |
- Citation: Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017; 9(12): 603-612
- URL: https://www.wjgnet.com/1948-5182/full/v9/i12/603.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i12.603